Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy

Tumor growth rate (TGR; percent size change per month [%/m]) is postulated as an early radio-graphic predictor of response to anti-cancer treatment to overcome limitations of RECIST. We aimed to evaluate the predictive value of pre-treatment TGR (TGR0) for outcomes of advanced non-small cell lung ca...

Full description

Bibliographic Details
Main Authors: Li-na He, Xuanye Zhang, Haifeng Li, Tao Chen, Chen Chen, Yixin Zhou, Zuan Lin, Wei Du, Wenfeng Fang, Yunpeng Yang, Yan Huang, Hongyun Zhao, Shaodong Hong, Li Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Oncology
Subjects:
progression-free survival
non-small cell lung cancer
NSCLC
anti-PD-1/PD-L1 therapy
immunotherapy
tumor growth rate
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.621329/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.621329/full

Similar Items